Secunderabad Healthcare Ltd.
BSE: 524540 | Sector: Health care |
NSE: N.A. | ISIN Code: INE930C01016 |
BSE 00:00 | 04 Mar | Secunderabad Healthcare Ltd |
NSE 05:30 | 01 Jan | Secunderabad Healthcare Ltd |
OPEN | 6.17 |
PREVIOUS CLOSE | 5.99 |
VOLUME | 309707 |
52-Week high | 6.17 |
52-Week low | 0.00 |
P/E | |
Mkt Cap.(Rs cr) | 50 |
Buy Price | 5.77 |
Buy Qty | 25.00 |
Sell Price | 6.10 |
Sell Qty | 492.00 |
Secunderabad Healthcare Ltd. (SECUNDHEALTH) - News Sector
-
Pharma firm Divi's FY23 growth shaped by high base, near-term weakness
7.15 pm | 17 Aug 2022 | Business Standard
Brokerages give add, accumulate or buy ratings given the company's growth and track record
-
GIC, Capital Group buy KKR's entire stake in Max Health; stock surges 10%
12.21 am | 17 Aug 2022 | Business Standard
KKR sold the entire 26.8% stake worth Rs 9,400 cr as part of its exit strategy
-
USFDA approves Aurobindo Pharma owned Eugia's generic Vasopressin injection
2.04 pm | 16 Aug 2022 | Press Trust of India
Aurobindo Pharma Ltd on Tuesday said its wholly-owned arm Eugia Pharma Specialties Ltd has received final approval from the US health regulator for it...
-
KKR to sell entire 26% Max Healthcare stake for Rs 9,416 crore today
1.26 am | 16 Aug 2022 | BS Reporter
American PE major exits from hospital chain after acquiring the stake in 2018
-
Lupin revising product portfolio in US to overcome price erosion impact
1.34 am | 15 Aug 2022 | Press Trust of India
Homegrown pharmaceutical firm Lupin Ltd is rationalising its product portfolio in the US, transitioning from simple oral solid medicines to more compl...
-
NCLT approves the demerger of Piramal Enterprises' pharma business
12.44 am | 13 Aug 2022 | Business Standard
This paves the way towards creation of two separate listed entities - Piramal Enterprises and Piramal Pharma
-
F&O Strategy: Nandish Shah recommends a Bull Spread on Lupin
8.27 am | 12 Aug 2022 | Business Standard
The technical analyst from HDFC Securities recommends buying Lupin 700 Call and simultaneously selling 720 Call for the August series.
-
Max Healthcare Q1 net profit up 12% at Rs 229 cr; revenue rises 5%
3.49 pm | 10 Aug 2022 | Press Trust of India
'Q1FY23 performance reflects normalisation of revenues and operating EBITDA post Omicron wave in the previous quarter,' Max Healthcare Chairman and MD...
-
Apollo Hospitals acquires asset from Nayati Healthcare for Rs 450 crore
1.56 am | 9 Aug 2022 | Business Standard
The hospital asset was sold by DLF Qutub Enclave Complex Medical Charitable Trust in 2011 to Nayati Healthcare and Research NCR Pvt Ltd
-
Lupin reports Q1 net loss at Rs 89 cr on lower US sales; revenue falls 12%
9.30 pm | 4 Aug 2022 | Press Trust of India
'Our numbers are muted this quarter, but we expect a strong bounce back from Q2 onwards,' says Lupin MD
-
Here's why Vinay Rajani recommends buying Indoco Remedies, PTC India
7.54 am | 3 Aug 2022 | Business Standard
The technical analyst from HDFC Securities said traders should wait for correction to enter fresh longs on the Nifty index.
-
We're geared to launch a new molecule every 1-2 years: Biocon Biologics MD
12.46 pm | 2 Aug 2022 | Business Standard
In an interview, Arun Chandravarkar explains why a company must continue investing in R&D despite the impact on short-term Ebitda
-
Piramal Group charts growth path for financial services business
3.46 pm | 1 Aug 2022 | Press Trust of India
'We are on track to achieve retail loan disbursements of Rs 2,500 cr-3,500 cr in Q3FY23,' which is 5-7 times of pre-merger levels, says Piramal Group ...
-
Sun Pharma stock likely to keep shining amid global specialty scale-up
11.48 pm | 31 Jul 2022 | Business Standard
Focus on key markets to help expand branded formulations business, say experts
-
Cipla Q1 net dips 4% to Rs 686 cr, revenue down 2% on tapering Covid sales
10.06 pm | 29 Jul 2022 | Business Standard
Domestic revenue dips 8.4% as Covid-19 share of branded prescription business normalises; North American business up 10% to $155 million
-
Sun Pharma Q1 net up 43% to Rs 2,061 crore on specialty sales, India biz
10.00 pm | 29 Jul 2022 | Business Standard
Gross sales up 10.1% YoY to Rs 10,644 cr; EBITDA at Rs 2,884.4 cr, with a margin of 26.8%
-
Top headlines: HDFC Q1 net rises 22%; IOC posts Rs 1,993-cr net loss in Q1
5.27 pm | 29 Jul 2022 | Business Standard
Swiggy announced on Friday that it has extended its 'Future of Work' policy and announced a permanent work-from-anywhere for majority of roles.
-
Cipla Q1 net profit dips marginally to Rs 706 cr; revenue falls 2%
4.30 pm | 29 Jul 2022 | Press Trust of India
The Mumbai-based company had reported a net profit of Rs 710 crore in the April-June quarter of the last fisca
-
Strong India growth boosts DRL Q1 profit by 108% to Rs 1,188 crore
11.37 pm | 28 Jul 2022 | Business Standard
The DRL stock was down marginally (0.73 per cent) to Rs 4,254 on the BSE on Thursday
-
Dr Reddy's Q1 PAT soars 108% to Rs 1,188 cr; revenue rises 6%
6.34 pm | 28 Jul 2022 | Press Trust of India
Other operating income was at Rs 600 crore compared to Rs 50 crore in Q1FY22
Quick Links for Secunderabad Healthcare:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices